Torrent Pharma Plans Rs 19,500 Cr Deal to Acquire JB Chemicals

Torrent Pharmaceuticals has sought the Competition Commission of India (CCI) clearance for its planned ?19,500 crore acquisition of a majority holding in JB Chemicals & Pharmaceuticals.

Venus Remedies Secures WHO GDP for Top-Tier Drug Distribution

Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven pharmaceutical company, has once again received the World Health Organization (WHO) Good Distribution Practices (GDP)

CDSCO Pushes COPP Application Deadline for Pharma Firms to Aug 15

The Central Drugs Standard Control Organisation (CDSCO) further prolonged the deadline for pharma firms to file online applications for the WHO Good Manufacturing Practices (GMP) Certificate of Pharmaceutical Product (COPP) to August 15, 2025.

India's Pharma & Healthcare Deals Hit $1.3B in Q2 2025

India's pharmaceutical and healthcare industry saw 57 deals worth $1.3 billion in IPO and Qualified Institutional Placement (QIP) deal activity in the quarter ending June 2025, based on a report by Grant Thornton Bharat.

India and Uzbekistan Set to Expand Pharma and Healthcare Cooperation

India and Uzbekistan are set to increase cooperation in the pharmaceutical and medical industries after a virtual high-level discussion involving stakeholders of both countries. The session had stakeholders from Pharmexcil

Pharmexcil Seeks Transition Time for New COPP Export Rule Change

An organization that promotes exports stated that a new law that centralizes the licensing procedure for medicine exports through a web portal might reduce shipments by over 45%, asking for time to transition to the new system.

Small Pharma Faces Hurdles in Meeting Revised Schedule M Compliance

Indian small pharma firms are struggling with the complex requirements of the new Schedule M rules, with December 31, 2025, looming near. Harish K Jain, director at Embiotic Labs and president of the Federation of Pharmaceutical Entrepreneurs

Telangana Pharma Leaders Push for Safety as Pillar of Growth

At the CII Telangana, "Pillars of Protection" conference on pharmaceutical manufacturing safety in Hyderabad, government officials and industry professionals highlighted that safety needs to be embedded in every aspect of their operations...

India's Pharma Sector Faces Scrutiny as NITI Aayog Demands Change

NITI Aayog requested across-the-board quality makeover of India's pharma industry, while top industry bodies rang alarm bells on systemic issues that are stifling compliance with international standards.

India and Uzbekistan to Boost Pharma Ties for Stronger Trade Links

Building on recent efforts to enhance healthcare and pharmaceutical cooperation, India and Uzbekistan are eager to explore new areas of collaboration following a virtual session.

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring